Market Access Archives

Case Study

Using Real Word Evidence to Enhance Drug Development

Real-world evidence (RWE) has emerged as an increasingly important tool in the drug development process,1…

CertaraApril 5, 2023

Case Study

Agent-Based Model Predicts Impact of Monoclonal Antibody Treatment, Prophylaxis & Vaccines on Viral Transmission during Pandemic

Agent-based models focus on the heterogeneous behavior of individual agents and their interactions with one…

CertaraMarch 2, 2023

White Paper

Using Real-world Evidence to Advance Market Access for New Therapeutics

CertaraSeptember 29, 2021

On-Demand Webinar

The Scary Future of Rare Disease Management

In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug…

CertaraSeptember 23, 2021

Blog

Succeeding in Value Communication: Introduction

Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding…

CertaraAugust 5, 2021

Video

What is BaseCase?

Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams…

CertaraJuly 20, 2021

On-Demand Webinar

Three Pathways have emerged in Innovative Access Agreements

The days of simply determining the market demand for a new drug as a function…

CertaraJune 11, 2021

On-Demand Webinar

Outcomes Based Agreements

The days of simply determining the market demand for a new drug as a function…

CertaraJune 11, 2021

On-Demand Webinar

Stakeholder perspectives: current and potential benefits

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

CertaraMay 26, 2021

On-Demand Webinar

Strengths and opportunities for HTAs and market access in Europe through case studies

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

CertaraMay 26, 2021

Market Access

Using Real Word Evidence to Enhance Drug Development

Agent-Based Model Predicts Impact of Monoclonal Antibody Treatment, Prophylaxis & Vaccines on Viral Transmission during Pandemic

Using Real-world Evidence to Advance Market Access for New Therapeutics

The Scary Future of Rare Disease Management

Succeeding in Value Communication: Introduction

What is BaseCase?

Three Pathways have emerged in Innovative Access Agreements

Outcomes Based Agreements

Stakeholder perspectives: current and potential benefits

Strengths and opportunities for HTAs and market access in Europe through case studies

Newsletter sign up

Quick links

Solutions

Contact